University of Minnesota Clinical Research Unit — Minneapolis, Minnesota

University of Minnesota Clinical Research Unit is a clinical research site located in Minneapolis, Minnesota, United States 55454.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Minnesota Clinical Research Unit has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Cytomegalovirus Infection, Advanced Solid Tumor, Thrombotic Thrombocytopenic Purpura (TTP).

Sponsors: ModernaTX, Inc., Eikon Therapeutics, Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Minnesota Clinical Research Unit?

University of Minnesota Clinical Research Unit has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Minnesota Clinical Research Unit conducted?

University of Minnesota Clinical Research Unit has 5 clinical trials on record, with 1 currently active. Their work covers Cytomegalovirus Infection, Advanced Solid Tumor, Thrombotic Thrombocytopenic Purpura (TTP).

Is University of Minnesota Clinical Research Unit accredited by Crixeo Clinical Trials?

University of Minnesota Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Minnesota Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.